Remdesivir in kidney transplant patients with SARS-CoV-2 pneumonia()

BACKGROUND: Remdesivir is the only antiviral treatment that has been shown to be useful against SARS-CoV-2 infection. It shorts hospitalization time compared to placebo. Its effects in Kidney transplant (KT) patients are limited to some published cases. METHODS: We performed a retrospective observat...

Descripción completa

Detalles Bibliográficos
Autores principales: Cacho, Judit, Burgos, Elena, Molina, María, Villegas, Andrés, Pérez, Mónica, Cañas, Laura, Taco, Omar, Juega, Javier, Lauzurica, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Nefrología. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343742/
https://www.ncbi.nlm.nih.gov/pubmed/36210620
http://dx.doi.org/10.1016/j.nefroe.2022.07.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343742/
https://www.ncbi.nlm.nih.gov/pubmed/36210620
http://dx.doi.org/10.1016/j.nefroe.2022.07.006

Ejemplares similares